NIH-funded research R01 grant

How human milk oligosaccharides help protect the gut and reduce inflammation

Official title: Mechanisms by which human milk-derived oligosaccharides protect intestinal barrier and attenuate inflammation

Funded at Vanderbilt University Medical Center · NIH-11088883 · Data updated 2026-11-12

This study is looking at how certain sugars in human milk, especially one called 2’-fucosyllactose, can help protect the gut and keep it healthy, which could be really helpful for both babies and adults dealing with gut issues like inflammatory bowel disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startMay 15, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$561,164
NIH project number5R01DK136893-02
Project IDNIH-11088883 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from inflammatory bowel diseases or those experiencing complications from chemotherapy.

Less likely to help

Patients with intact intestinal barriers and no history of gut-related diseases may not benefit from this research.

What this research studies

This research investigates the protective effects of oligosaccharides found in human milk on the intestinal barrier, which is crucial for preventing diseases like inflammatory bowel disease and mucositis. The study focuses on understanding how these oligosaccharides, particularly 2’-fucosyllactose, function at a biological level to support gut health in both infants and adults. By exploring the mechanisms through which these compounds promote beneficial gut bacteria and protect against intestinal injury, the research aims to identify potential therapeutic applications for patients suffering from gut-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance gut health and reduce inflammation for patients with intestinal disorders.

How similar studies have gone: Previous research has shown promising results regarding the benefits of human milk oligosaccharides in gut health, suggesting that this approach has potential for success.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Yan, Fang — Vanderbilt University Medical Center
  • Study coordinator: Yan, Fang

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.